ArticleJournal of translational medicine2019

Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.

Xavier Ruiz-Plazas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.